Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.39B
Enterprise Value9.68B
P/E Ratio-3.17
PEG Ratio-0
Price/Sales Ratio13.03
Price/Book Ratio0.82
Enterprise/Revenue21.18
Enterprise/EBITDA-5.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-4.11
Operating Margin-2.39
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.24

Income Statement

Revenue798.06M
Revenue/Share0.4
Gross Profit-22.06M
EBITDA-1.31B
Net Income-1.37B
Diluted EPS-1.45

Balance Sheet

Total Cash69.12M
Total Cash/Share0.07
Total Debt3.16B
Total Debt/Equity0.53
Current Ratio1.32
Book Value Per Share6.44

Price History

52-Week Change-54.66
52-Week High12.3
52-Week Low4.21
Moving Average 50 Days5.91
Moving Average 200 Days6.95

Statistics

Average Volume54.16M
Shares Outstanding940.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor2:1
Last Split DateJune 13, 2016
AD